![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:ADH1B-ALB (FusionGDB2 ID:HG125TG213) |
Fusion Gene Summary for ADH1B-ALB |
![]() |
Fusion gene information | Fusion gene name: ADH1B-ALB | Fusion gene ID: hg125tg213 | Hgene | Tgene | Gene symbol | ADH1B | ALB | Gene ID | 125 | 213 |
Gene name | alcohol dehydrogenase 1B (class I), beta polypeptide | albumin | |
Synonyms | ADH2|HEL-S-117 | HSA|PRO0883|PRO0903|PRO1341 | |
Cytomap | ('ADH1B')('ALB') 4q23 | 4q13.3 | |
Type of gene | protein-coding | protein-coding | |
Description | all-trans-retinol dehydrogenase [NAD(+)] ADH1BADH, beta subunitalcohol dehydrogenase 2 (class I), beta polypeptidealcohol dehydrogenase subunit betaaldehyde reductaseepididymis secretory protein Li 117 | serum albumin | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000305046, ENST00000394887, ENST00000504498, | ||
Fusion gene scores | * DoF score | 3 X 3 X 2=18 | 49 X 62 X 5=15190 |
# samples | 3 | 64 | |
** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(64/15190*10)=-4.56890615450208 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ADH1B [Title/Abstract] AND ALB [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ADH1B(100242471)-ALB(74279137), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | ADH1B-ALB seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ADH1B-ALB seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ADH1B-ALB seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ADH1B-ALB seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ADH1B | GO:0001523 | retinoid metabolic process | 15369820|16787387 |
Hgene | ADH1B | GO:0006069 | ethanol oxidation | 2398055 |
Tgene | ALB | GO:0009267 | cellular response to starvation | 16245148 |
Tgene | ALB | GO:0043066 | negative regulation of apoptotic process | 16153637 |
Tgene | ALB | GO:0051659 | maintenance of mitochondrion location | 16153637 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | Non-Cancer | TCGA-DD-A11C-11A | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
Top |
Fusion Gene ORF analysis for ADH1B-ALB |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-3UTR | ENST00000305046 | ENST00000505649 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
5UTR-3CDS | ENST00000394887 | ENST00000295897 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
5UTR-3CDS | ENST00000394887 | ENST00000401494 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
5UTR-3CDS | ENST00000394887 | ENST00000415165 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
5UTR-3CDS | ENST00000394887 | ENST00000503124 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
5UTR-3CDS | ENST00000394887 | ENST00000509063 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
5UTR-3CDS | ENST00000504498 | ENST00000295897 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
5UTR-3CDS | ENST00000504498 | ENST00000401494 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
5UTR-3CDS | ENST00000504498 | ENST00000415165 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
5UTR-3CDS | ENST00000504498 | ENST00000503124 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
5UTR-3CDS | ENST00000504498 | ENST00000509063 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
5UTR-3UTR | ENST00000394887 | ENST00000505649 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
5UTR-3UTR | ENST00000504498 | ENST00000505649 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
In-frame | ENST00000305046 | ENST00000295897 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
In-frame | ENST00000305046 | ENST00000401494 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
In-frame | ENST00000305046 | ENST00000415165 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
In-frame | ENST00000305046 | ENST00000503124 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
In-frame | ENST00000305046 | ENST00000509063 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000305046 | ADH1B | chr4 | 100242471 | - | ENST00000295897 | ALB | chr4 | 74279137 | + | 1417 | 86 | 38 | 1072 | 344 |
ENST00000305046 | ADH1B | chr4 | 100242471 | - | ENST00000415165 | ALB | chr4 | 74279137 | + | 1261 | 86 | 38 | 1072 | 344 |
ENST00000305046 | ADH1B | chr4 | 100242471 | - | ENST00000503124 | ALB | chr4 | 74279137 | + | 1227 | 86 | 38 | 1072 | 344 |
ENST00000305046 | ADH1B | chr4 | 100242471 | - | ENST00000509063 | ALB | chr4 | 74279137 | + | 1130 | 86 | 38 | 1057 | 339 |
ENST00000305046 | ADH1B | chr4 | 100242471 | - | ENST00000401494 | ALB | chr4 | 74279137 | + | 1227 | 86 | 38 | 1072 | 344 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000305046 | ENST00000295897 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + | 0.001435951 | 0.99856406 |
ENST00000305046 | ENST00000415165 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + | 0.001506765 | 0.9984932 |
ENST00000305046 | ENST00000503124 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + | 0.001216141 | 0.9987839 |
ENST00000305046 | ENST00000509063 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + | 0.002062079 | 0.99793786 |
ENST00000305046 | ENST00000401494 | ADH1B | chr4 | 100242471 | - | ALB | chr4 | 74279137 | + | 0.001216141 | 0.9987839 |
Top |
Fusion Genomic Features for ADH1B-ALB |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
ADH1B | chr4 | 100242470 | - | ALB | chr4 | 74279136 | + | 0.44113424 | 0.5588658 |
ADH1B | chr4 | 100242470 | - | ALB | chr4 | 74279136 | + | 0.44113424 | 0.5588658 |
![]() |
![]() |
![]() |
![]() |
Top |
Fusion Protein Features for ADH1B-ALB |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr4:100242471/chr4:74279137) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | ALB | chr4:100242471 | chr4:74279137 | ENST00000295897 | 6 | 15 | 404_601 | 281 | 661.0 | Domain | Albumin 3 | |
Tgene | ALB | chr4:100242471 | chr4:74279137 | ENST00000509063 | 6 | 14 | 404_601 | 281 | 605.0 | Domain | Albumin 3 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ADH1B | chr4:100242471 | chr4:74279137 | ENST00000305046 | - | 1 | 9 | 200_205 | 6 | 376.0 | Nucleotide binding | Note=NAD |
Hgene | ADH1B | chr4:100242471 | chr4:74279137 | ENST00000305046 | - | 1 | 9 | 293_295 | 6 | 376.0 | Nucleotide binding | Note=NAD |
Tgene | ALB | chr4:100242471 | chr4:74279137 | ENST00000295897 | 6 | 15 | 19_210 | 281 | 661.0 | Domain | Albumin 1 | |
Tgene | ALB | chr4:100242471 | chr4:74279137 | ENST00000295897 | 6 | 15 | 211_403 | 281 | 661.0 | Domain | Albumin 2 | |
Tgene | ALB | chr4:100242471 | chr4:74279137 | ENST00000509063 | 6 | 14 | 19_210 | 281 | 605.0 | Domain | Albumin 1 | |
Tgene | ALB | chr4:100242471 | chr4:74279137 | ENST00000509063 | 6 | 14 | 211_403 | 281 | 605.0 | Domain | Albumin 2 |
Top |
Fusion Gene Sequence for ADH1B-ALB |
![]() |
>2410_2410_1_ADH1B-ALB_ADH1B_chr4_100242471_ENST00000305046_ALB_chr4_74279137_ENST00000295897_length(transcript)=1417nt_BP=86nt GCACTCAAGCAGAGAAGAAATCCACAAAGACTCACAGTCTGCTGGTGGGCAGAGAAGACAGAAACGACATGAGCACAGCAGGAAAAGCGG ACCTTGCCAAGTATATCTGTGAAAATCAAGATTCGATCTCCAGTAAACTGAAGGAATGCTGTGAAAAACCTCTGTTGGAAAAATCCCACT GCATTGCCGAAGTGGAAAATGATGAGATGCCTGCTGACTTGCCTTCATTAGCTGCTGATTTTGTTGAAAGTAAGGATGTTTGCAAAAACT ATGCTGAGGCAAAGGATGTCTTCCTGGGCATGTTTTTGTATGAATATGCAAGAAGGCATCCTGATTACTCTGTCGTGCTGCTGCTGAGAC TTGCCAAGACATATGAAACCACTCTAGAGAAGTGCTGTGCCGCTGCAGATCCTCATGAATGCTATGCCAAAGTGTTCGATGAATTTAAAC CTCTTGTGGAAGAGCCTCAGAATTTAATCAAACAAAATTGTGAGCTTTTTGAGCAGCTTGGAGAGTACAAATTCCAGAATGCGCTATTAG TTCGTTACACCAAGAAAGTACCCCAAGTGTCAACTCCAACTCTTGTAGAGGTCTCAAGAAACCTAGGAAAAGTGGGCAGCAAATGTTGTA AACATCCTGAAGCAAAAAGAATGCCCTGTGCAGAAGACTATCTATCCGTGGTCCTGAACCAGTTATGTGTGTTGCATGAGAAAACGCCAG TAAGTGACAGAGTCACCAAATGCTGCACAGAATCCTTGGTGAACAGGCGACCATGCTTTTCAGCTCTGGAAGTCGATGAAACATACGTTC CCAAAGAGTTTAATGCTGAAACATTCACCTTCCATGCAGATATATGCACACTTTCTGAGAAGGAGAGACAAATCAAGAAACAAACTGCAC TTGTTGAGCTCGTGAAACACAAGCCCAAGGCAACAAAAGAGCAACTGAAAGCTGTTATGGATGATTTCGCAGCTTTTGTAGAGAAGTGCT GCAAGGCTGACGATAAGGAGACCTGCTTTGCCGAGGAGGGTAAAAAACTTGTTGCTGCAAGTCAAGCTGCCTTAGGCTTATAACATCACA TTTAAAAGCATCTCAGCCTACCATGAGAATAAGAGAAAGAAAATGAAGATCAAAAGCTTATTCATCTGTTTTTCTTTTTCGTTGGTGTAA AGCCAACACCCTGTCTAAAAAACATAAATTTCTTTAATCATTTTGCCTCTTTTCTCTGTGCTTCAATTAATAAAAAATGGAAAGAATCTA ATAGAGTGGTACAGCACTGTTATTTTTCAAAGATGTGTTGCTATCCTGAAAATTCTGTAGGTTCTGTGGAAGTTCCAGTGTTCTCTCTTA >2410_2410_1_ADH1B-ALB_ADH1B_chr4_100242471_ENST00000305046_ALB_chr4_74279137_ENST00000295897_length(amino acids)=344AA_BP=16 MLVGREDRNDMSTAGKADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFL YEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTP TLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHA -------------------------------------------------------------- >2410_2410_2_ADH1B-ALB_ADH1B_chr4_100242471_ENST00000305046_ALB_chr4_74279137_ENST00000401494_length(transcript)=1227nt_BP=86nt GCACTCAAGCAGAGAAGAAATCCACAAAGACTCACAGTCTGCTGGTGGGCAGAGAAGACAGAAACGACATGAGCACAGCAGGAAAAGCGG ACCTTGCCAAGTATATCTGTGAAAATCAAGATTCGATCTCCAGTAAACTGAAGGAATGCTGTGAAAAACCTCTGTTGGAAAAATCCCACT GCATTGCCGAAGTGGAAAATGATGAGATGCCTGCTGACTTGCCTTCATTAGCTGCTGATTTTGTTGAAAGTAAGGATGTTTGCAAAAACT ATGCTGAGGCAAAGGATGTCTTCCTGGGCATGTTTTTGTATGAATATGCAAGAAGGCATCCTGATTACTCTGTCGTGCTGCTGCTGAGAC TTGCCAAGACATATGAAACCACTCTAGAGAAGTGCTGTGCCGCTGCAGATCCTCATGAATGCTATGCCAAAGTGTTCGATGAATTTAAAC CTCTTGTGGAAGAGCCTCAGAATTTAATCAAACAAAATTGTGAGCTTTTTGAGCAGCTTGGAGAGTACAAATTCCAGAATGCGCTATTAG TTCGTTACACCAAGAAAGTACCCCAAGTGTCAACTCCAACTCTTGTAGAGGTCTCAAGAAACCTAGGAAAAGTGGGCAGCAAATGTTGTA AACATCCTGAAGCAAAAAGAATGCCCTGTGCAGAAGACTATCTATCCGTGGTCCTGAACCAGTTATGTGTGTTGCATGAGAAAACGCCAG TAAGTGACAGAGTCACCAAATGCTGCACAGAATCCTTGGTGAACAGGCGACCATGCTTTTCAGCTCTGGAAGTCGATGAAACATACGTTC CCAAAGAGTTTAATGCTGAAACATTCACCTTCCATGCAGATATATGCACACTTTCTGAGAAGGAGAGACAAATCAAGAAACAAACTGCAC TTGTTGAGCTCGTGAAACACAAGCCCAAGGCAACAAAAGAGCAACTGAAAGCTGTTATGGATGATTTCGCAGCTTTTGTAGAGAAGTGCT GCAAGGCTGACGATAAGGAGACCTGCTTTGCCGAGGAGGGTAAAAAACTTGTTGCTGCAAGTCAAGCTGCCTTAGGCTTATAACATCACA TTTAAAAGCATCTCAGCCTACCATGAGAATAAGAGAAAGAAAATGAAGATCAAAAGCTTATTCATCTGTTTTTCTTTTTCGTTGGTGTAA >2410_2410_2_ADH1B-ALB_ADH1B_chr4_100242471_ENST00000305046_ALB_chr4_74279137_ENST00000401494_length(amino acids)=344AA_BP=16 MLVGREDRNDMSTAGKADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFL YEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTP TLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHA -------------------------------------------------------------- >2410_2410_3_ADH1B-ALB_ADH1B_chr4_100242471_ENST00000305046_ALB_chr4_74279137_ENST00000415165_length(transcript)=1261nt_BP=86nt GCACTCAAGCAGAGAAGAAATCCACAAAGACTCACAGTCTGCTGGTGGGCAGAGAAGACAGAAACGACATGAGCACAGCAGGAAAAGCGG ACCTTGCCAAGTATATCTGTGAAAATCAAGATTCGATCTCCAGTAAACTGAAGGAATGCTGTGAAAAACCTCTGTTGGAAAAATCCCACT GCATTGCCGAAGTGGAAAATGATGAGATGCCTGCTGACTTGCCTTCATTAGCTGCTGATTTTGTTGAAAGTAAGGATGTTTGCAAAAACT ATGCTGAGGCAAAGGATGTCTTCCTGGGCATGTTTTTGTATGAATATGCAAGAAGGCATCCTGATTACTCTGTCGTGCTGCTGCTGAGAC TTGCCAAGACATATGAAACCACTCTAGAGAAGTGCTGTGCCGCTGCAGATCCTCATGAATGCTATGCCAAAGTGTTCGATGAATTTAAAC CTCTTGTGGAAGAGCCTCAGAATTTAATCAAACAAAATTGTGAGCTTTTTGAGCAGCTTGGAGAGTACAAATTCCAGAATGCGCTATTAG TTCGTTACACCAAGAAAGTACCCCAAGTGTCAACTCCAACTCTTGTAGAGGTCTCAAGAAACCTAGGAAAAGTGGGCAGCAAATGTTGTA AACATCCTGAAGCAAAAAGAATGCCCTGTGCAGAAGACTATCTATCCGTGGTCCTGAACCAGTTATGTGTGTTGCATGAGAAAACGCCAG TAAGTGACAGAGTCACCAAATGCTGCACAGAATCCTTGGTGAACAGGCGACCATGCTTTTCAGCTCTGGAAGTCGATGAAACATACGTTC CCAAAGAGTTTAATGCTGAAACATTCACCTTCCATGCAGATATATGCACACTTTCTGAGAAGGAGAGACAAATCAAGAAACAAACTGCAC TTGTTGAGCTCGTGAAACACAAGCCCAAGGCAACAAAAGAGCAACTGAAAGCTGTTATGGATGATTTCGCAGCTTTTGTAGAGAAGTGCT GCAAGGCTGACGATAAGGAGACCTGCTTTGCCGAGGAGGGTAAAAAACTTGTTGCTGCAAGTCAAGCTGCCTTAGGCTTATAACATCACA TTTAAAAGCATCTCAGCCTACCATGAGAATAAGAGAAAGAAAATGAAGATCAAAAGCTTATTCATCTGTTTTTCTTTTTCGTTGGTGTAA AGCCAACACCCTGTCTAAAAAACATAAATTTCTTTAATCATTTTGCCTCTTTTCTCTGTGCTTCAATTAATAAAAAATGGAAAGAATCTA >2410_2410_3_ADH1B-ALB_ADH1B_chr4_100242471_ENST00000305046_ALB_chr4_74279137_ENST00000415165_length(amino acids)=344AA_BP=16 MLVGREDRNDMSTAGKADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFL YEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTP TLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHA -------------------------------------------------------------- >2410_2410_4_ADH1B-ALB_ADH1B_chr4_100242471_ENST00000305046_ALB_chr4_74279137_ENST00000503124_length(transcript)=1227nt_BP=86nt GCACTCAAGCAGAGAAGAAATCCACAAAGACTCACAGTCTGCTGGTGGGCAGAGAAGACAGAAACGACATGAGCACAGCAGGAAAAGCGG ACCTTGCCAAGTATATCTGTGAAAATCAAGATTCGATCTCCAGTAAACTGAAGGAATGCTGTGAAAAACCTCTGTTGGAAAAATCCCACT GCATTGCCGAAGTGGAAAATGATGAGATGCCTGCTGACTTGCCTTCATTAGCTGCTGATTTTGTTGAAAGTAAGGATGTTTGCAAAAACT ATGCTGAGGCAAAGGATGTCTTCCTGGGCATGTTTTTGTATGAATATGCAAGAAGGCATCCTGATTACTCTGTCGTGCTGCTGCTGAGAC TTGCCAAGACATATGAAACCACTCTAGAGAAGTGCTGTGCCGCTGCAGATCCTCATGAATGCTATGCCAAAGTGTTCGATGAATTTAAAC CTCTTGTGGAAGAGCCTCAGAATTTAATCAAACAAAATTGTGAGCTTTTTGAGCAGCTTGGAGAGTACAAATTCCAGAATGCGCTATTAG TTCGTTACACCAAGAAAGTACCCCAAGTGTCAACTCCAACTCTTGTAGAGGTCTCAAGAAACCTAGGAAAAGTGGGCAGCAAATGTTGTA AACATCCTGAAGCAAAAAGAATGCCCTGTGCAGAAGACTATCTATCCGTGGTCCTGAACCAGTTATGTGTGTTGCATGAGAAAACGCCAG TAAGTGACAGAGTCACCAAATGCTGCACAGAATCCTTGGTGAACAGGCGACCATGCTTTTCAGCTCTGGAAGTCGATGAAACATACGTTC CCAAAGAGTTTAATGCTGAAACATTCACCTTCCATGCAGATATATGCACACTTTCTGAGAAGGAGAGACAAATCAAGAAACAAACTGCAC TTGTTGAGCTCGTGAAACACAAGCCCAAGGCAACAAAAGAGCAACTGAAAGCTGTTATGGATGATTTCGCAGCTTTTGTAGAGAAGTGCT GCAAGGCTGACGATAAGGAGACCTGCTTTGCCGAGGAGGGTAAAAAACTTGTTGCTGCAAGTCAAGCTGCCTTAGGCTTATAACATCACA TTTAAAAGCATCTCAGCCTACCATGAGAATAAGAGAAAGAAAATGAAGATCAAAAGCTTATTCATCTGTTTTTCTTTTTCGTTGGTGTAA >2410_2410_4_ADH1B-ALB_ADH1B_chr4_100242471_ENST00000305046_ALB_chr4_74279137_ENST00000503124_length(amino acids)=344AA_BP=16 MLVGREDRNDMSTAGKADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFL YEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTP TLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHA -------------------------------------------------------------- >2410_2410_5_ADH1B-ALB_ADH1B_chr4_100242471_ENST00000305046_ALB_chr4_74279137_ENST00000509063_length(transcript)=1130nt_BP=86nt GCACTCAAGCAGAGAAGAAATCCACAAAGACTCACAGTCTGCTGGTGGGCAGAGAAGACAGAAACGACATGAGCACAGCAGGAAAAGCGG ACCTTGCCAAGTATATCTGTGAAAATCAAGATTCGATCTCCAGTAAACTGAAGGAATGCTGTGAAAAACCTCTGTTGGAAAAATCCCACT GCATTGCCGAAGTGGAAAATGATGAGATGCCTGCTGACTTGCCTTCATTAGCTGCTGATTTTGTTGAAAGTAAGGATGTTTGCAAAAACT ATGCTGAGGCAAAGGATGTCTTCCTGGGCATGTTTTTGTATGAATATGCAAGAAGGCATCCTGATTACTCTGTCGTGCTGCTGCTGAGAC TTGCCAAGACATATGAAACCACTCTAGAGAAGTGCTGTGCCGCTGCAGATCCTCATGAATGCTATGCCAAAGTGTTCGATGAATTTAAAC CTCTTGTGGAAGAGCCTCAGAATTTAATCAAACAAAATTGTGAGCTTTTTGAGCAGCTTGGAGAGTACAAATTCCAGAATGCGCTATTAG TTCGTTACACCAAGAAAGTACCCCAAGTGTCAACTCCAACTCTTGTAGAGGTCTCAAGAAACCTAGGAAAAGTGGGCAGCAAATGTTGTA AACATCCTGAAGCAAAAAGAATGCCCTGTGCAGAAGACTATCTATCCGTGGTCCTGAACCAGTTATGTGTGTTGCATGAGAAAACGCCAG TAAGTGACAGAGTCACCAAATGCTGCACAGAATCCTTGGTGAACAGGCGACCATGCTTTTCAGCTCTGGAAGTCGATGAAACATACGTTC CCAAAGAGTTTAATGCTGAAACATTCACCTTCCATGCAGATATATGCACACTTTCTGAGAAGGAGAGACAAATCAAGAAACAAACTGCAC TTGTTGAGCTCGTGAAACACAAGCCCAAGGCAACAAAAGAGCAACTGAAAGCTGTTATGGATGATTTCGCAGCTTTTGTAGAGAAGTGCT GCAAGGCTGACGATAAGGAGACCTGCTTTGCCGAGGAGCCTACCATGAGAATAAGAGAAAGAAAATGAAGATCAAAAGCTTATTCATCTG >2410_2410_5_ADH1B-ALB_ADH1B_chr4_100242471_ENST00000305046_ALB_chr4_74279137_ENST00000509063_length(amino acids)=339AA_BP=16 MLVGREDRNDMSTAGKADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFL YEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTP TLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHA -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ADH1B-ALB |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ADH1B-ALB |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ADH1B-ALB |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ADH1B | C0001973 | Alcoholic Intoxication, Chronic | 8 | CTD_human;PSYGENET |
Hgene | ADH1B | C0085762 | Alcohol abuse | 8 | CTD_human;PSYGENET |
Hgene | ADH1B | C0001969 | Alcoholic Intoxication | 5 | PSYGENET |
Hgene | ADH1B | C0001956 | Alcohol Use Disorder | 3 | CTD_human |
Hgene | ADH1B | C0007107 | Malignant neoplasm of larynx | 1 | CTD_human |
Hgene | ADH1B | C0007785 | Cerebral Infarction | 1 | CTD_human |
Hgene | ADH1B | C0009402 | Colorectal Carcinoma | 1 | CTD_human |
Hgene | ADH1B | C0009404 | Colorectal Neoplasms | 1 | CTD_human |
Hgene | ADH1B | C0014859 | Esophageal Neoplasms | 1 | CTD_human |
Hgene | ADH1B | C0023055 | Laryngeal neoplasm | 1 | CTD_human |
Hgene | ADH1B | C0026640 | Mouth Neoplasms | 1 | CTD_human |
Hgene | ADH1B | C0028754 | Obesity | 1 | CTD_human |
Hgene | ADH1B | C0031347 | Pharyngeal Neoplasms | 1 | CTD_human |
Hgene | ADH1B | C0033975 | Psychotic Disorders | 1 | PSYGENET |
Hgene | ADH1B | C0153381 | Malignant neoplasm of mouth | 1 | CTD_human |
Hgene | ADH1B | C0153405 | Malignant neoplasm of pharynx | 1 | CTD_human |
Hgene | ADH1B | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |
Hgene | ADH1B | C0349464 | Wernicke-Korsakoff Syndrome | 1 | PSYGENET |
Hgene | ADH1B | C0393756 | Hangover from alcohol | 1 | PSYGENET |
Hgene | ADH1B | C0400966 | Non-alcoholic Fatty Liver Disease | 1 | CTD_human |
Hgene | ADH1B | C0546837 | Malignant neoplasm of esophagus | 1 | CTD_human |
Hgene | ADH1B | C0751010 | Cerebral Infarction, Left Hemisphere | 1 | CTD_human |
Hgene | ADH1B | C0751011 | Cerebral Infarction, Right Hemisphere | 1 | CTD_human |
Hgene | ADH1B | C0751012 | Anterior Choroidal Artery Infarction | 1 | CTD_human |
Hgene | ADH1B | C0751014 | Subcortical Infarction | 1 | CTD_human |
Hgene | ADH1B | C0887799 | Posterior Choroidal Artery Infarction | 1 | CTD_human |
Hgene | ADH1B | C3241937 | Nonalcoholic Steatohepatitis | 1 | CTD_human |
Tgene | C0033687 | Proteinuria | 9 | CTD_human | |
Tgene | C0017658 | Glomerulonephritis | 8 | CTD_human | |
Tgene | C0022658 | Kidney Diseases | 8 | CTD_human | |
Tgene | C1704377 | Bright Disease | 8 | CTD_human | |
Tgene | C0017665 | Membranous glomerulonephritis | 6 | CTD_human | |
Tgene | C0027697 | Nephritis | 6 | CTD_human | |
Tgene | C0086445 | Idiopathic Membranous Glomerulonephritis | 6 | CTD_human | |
Tgene | C0342185 | Hyperthyroxinemia, Familial Dysalbuminemic | 6 | CTD_human;GENOMICS_ENGLAND;UNIPROT | |
Tgene | C1704378 | Heymann Nephritis | 6 | CTD_human | |
Tgene | C0022660 | Kidney Failure, Acute | 4 | CTD_human | |
Tgene | C0027707 | Nephritis, Interstitial | 4 | CTD_human | |
Tgene | C0038454 | Cerebrovascular accident | 4 | CTD_human | |
Tgene | C0041349 | Nephritis, Tubulointerstitial | 4 | CTD_human | |
Tgene | C0751956 | Acute Cerebrovascular Accidents | 4 | CTD_human | |
Tgene | C1565662 | Acute Kidney Insufficiency | 4 | CTD_human | |
Tgene | C2609414 | Acute kidney injury | 4 | CTD_human | |
Tgene | C0023893 | Liver Cirrhosis, Experimental | 3 | CTD_human | |
Tgene | C0025290 | Aseptic Meningitis | 3 | CTD_human | |
Tgene | C0013221 | Drug toxicity | 2 | CTD_human | |
Tgene | C0014544 | Epilepsy | 2 | CTD_human | |
Tgene | C0019193 | Hepatitis, Toxic | 2 | CTD_human | |
Tgene | C0020649 | Hypotension | 2 | CTD_human | |
Tgene | C0023890 | Liver Cirrhosis | 2 | CTD_human | |
Tgene | C0027726 | Nephrotic Syndrome | 2 | CTD_human | |
Tgene | C0036830 | Serum Sickness | 2 | CTD_human | |
Tgene | C0041755 | Adverse reaction to drug | 2 | CTD_human | |
Tgene | C0086237 | Epilepsy, Cryptogenic | 2 | CTD_human | |
Tgene | C0162557 | Liver Failure, Acute | 2 | CTD_human | |
Tgene | C0236018 | Aura | 2 | CTD_human | |
Tgene | C0239946 | Fibrosis, Liver | 2 | CTD_human | |
Tgene | C0751111 | Awakening Epilepsy | 2 | CTD_human | |
Tgene | C0860207 | Drug-Induced Liver Disease | 2 | CTD_human | |
Tgene | C0878666 | Analbuminemia | 2 | ORPHANET | |
Tgene | C1262760 | Hepatitis, Drug-Induced | 2 | CTD_human | |
Tgene | C3658290 | Drug-Induced Acute Liver Injury | 2 | CTD_human | |
Tgene | C4277682 | Chemical and Drug Induced Liver Injury | 2 | CTD_human | |
Tgene | C4279912 | Chemically-Induced Liver Toxicity | 2 | CTD_human | |
Tgene | C0002994 | Angioedema | 1 | CTD_human | |
Tgene | C0003460 | Anuria | 1 | CTD_human | |
Tgene | C0003865 | Arthritis, Adjuvant-Induced | 1 | CTD_human | |
Tgene | C0004509 | Azoospermia | 1 | CTD_human | |
Tgene | C0005398 | Cholestasis, Extrahepatic | 1 | CTD_human | |
Tgene | C0006111 | Brain Diseases | 1 | CTD_human | |
Tgene | C0007222 | Cardiovascular Diseases | 1 | CTD_human | |
Tgene | C0007786 | Brain Ischemia | 1 | CTD_human | |
Tgene | C0008312 | Primary biliary cirrhosis | 1 | CTD_human | |
Tgene | C0011573 | Endogenous depression | 1 | CTD_human | |
Tgene | C0011581 | Depressive disorder | 1 | CTD_human | |
Tgene | C0011875 | Diabetic Angiopathies | 1 | CTD_human | |
Tgene | C0011881 | Diabetic Nephropathy | 1 | CTD_human | |
Tgene | C0013502 | Echinococcosis | 1 | CTD_human | |
Tgene | C0014518 | Toxic Epidermal Necrolysis | 1 | CTD_human | |
Tgene | C0016059 | Fibrosis | 1 | CTD_human | |
Tgene | C0017662 | Glomerulonephritis, Membranoproliferative | 1 | CTD_human | |
Tgene | C0017667 | Nodular glomerulosclerosis | 1 | CTD_human | |
Tgene | C0018799 | Heart Diseases | 1 | CTD_human | |
Tgene | C0018801 | Heart failure | 1 | CTD_human | |
Tgene | C0018802 | Congestive heart failure | 1 | CTD_human | |
Tgene | C0019061 | Hemolytic-Uremic Syndrome | 1 | CTD_human | |
Tgene | C0019158 | Hepatitis | 1 | CTD_human | |
Tgene | C0019209 | Hepatomegaly | 1 | CTD_human | |
Tgene | C0019693 | HIV Infections | 1 | CTD_human | |
Tgene | C0019699 | HIV Seropositivity | 1 | CTD_human | |
Tgene | C0020517 | Hypersensitivity | 1 | CTD_human | |
Tgene | C0020522 | Delayed Hypersensitivity | 1 | CTD_human | |
Tgene | C0020538 | Hypertensive disease | 1 | CTD_human | |
Tgene | C0022548 | Keloid | 1 | CTD_human | |
Tgene | C0022661 | Kidney Failure, Chronic | 1 | CTD_human | |
Tgene | C0023212 | Left-Sided Heart Failure | 1 | CTD_human | |
Tgene | C0023892 | Biliary cirrhosis | 1 | CTD_human | |
Tgene | C0024623 | Malignant neoplasm of stomach | 1 | CTD_human | |
Tgene | C0025193 | Melancholia | 1 | CTD_human | |
Tgene | C0025945 | Microangiopathy, Diabetic | 1 | CTD_human | |
Tgene | C0026848 | Myopathy | 1 | CTD_human | |
Tgene | C0027055 | Myocardial Reperfusion Injury | 1 | CTD_human | |
Tgene | C0027720 | Nephrosis | 1 | CTD_human | |
Tgene | C0028797 | Occupational Diseases | 1 | CTD_human | |
Tgene | C0030193 | Pain | 1 | CTD_human | |
Tgene | C0030286 | Pancreatic Diseases | 1 | CTD_human | |
Tgene | C0030305 | Pancreatitis | 1 | CTD_human | |
Tgene | C0035222 | Respiratory Distress Syndrome, Adult | 1 | CTD_human | |
Tgene | C0035242 | Respiratory Tract Diseases | 1 | CTD_human | |
Tgene | C0035457 | Rhinitis, Allergic, Perennial | 1 | CTD_human | |
Tgene | C0038325 | Stevens-Johnson Syndrome | 1 | CTD_human | |
Tgene | C0038356 | Stomach Neoplasms | 1 | CTD_human | |
Tgene | C0040034 | Thrombocytopenia | 1 | CTD_human | |
Tgene | C0041696 | Unipolar Depression | 1 | CTD_human | |
Tgene | C0042109 | Urticaria | 1 | CTD_human | |
Tgene | C0042164 | Uveitis | 1 | CTD_human | |
Tgene | C0085584 | Encephalopathies | 1 | CTD_human | |
Tgene | C0086133 | Depressive Syndrome | 1 | CTD_human | |
Tgene | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human | |
Tgene | C0234230 | Pain, Burning | 1 | CTD_human | |
Tgene | C0234238 | Ache | 1 | CTD_human | |
Tgene | C0234254 | Radiating pain | 1 | CTD_human | |
Tgene | C0235527 | Heart Failure, Right-Sided | 1 | CTD_human | |
Tgene | C0238065 | Secondary Biliary Cholangitis | 1 | CTD_human | |
Tgene | C0239981 | Hypoalbuminemia | 1 | CTD_human | |
Tgene | C0268742 | Membranoproliferative Glomerulonephritis, Type I | 1 | CTD_human | |
Tgene | C0268743 | Membranoproliferative Glomerulonephritis, Type II | 1 | CTD_human | |
Tgene | C0273115 | Lung Injury | 1 | CTD_human | |
Tgene | C0282126 | Depression, Neurotic | 1 | CTD_human | |
Tgene | C0458257 | Pain, Splitting | 1 | CTD_human | |
Tgene | C0458259 | Pain, Crushing | 1 | CTD_human | |
Tgene | C0751407 | Pain, Migratory | 1 | CTD_human | |
Tgene | C0751408 | Suffering, Physical | 1 | CTD_human | |
Tgene | C0917798 | Cerebral Ischemia | 1 | CTD_human | |
Tgene | C0971858 | Arthritis, Collagen-Induced | 1 | CTD_human | |
Tgene | C0993582 | Arthritis, Experimental | 1 | CTD_human | |
Tgene | C1274933 | Drug-Induced Stevens Johnson Syndrome | 1 | CTD_human | |
Tgene | C1306571 | Hepatic Insufficiency | 1 | CTD_human | |
Tgene | C1527304 | Allergic Reaction | 1 | CTD_human | |
Tgene | C1623038 | Cirrhosis | 1 | CTD_human | |
Tgene | C1708349 | Hereditary Diffuse Gastric Cancer | 1 | CTD_human | |
Tgene | C1720821 | Membranoproliferative Glomerulonephritis, Type III | 1 | CTD_human | |
Tgene | C1959583 | Myocardial Failure | 1 | CTD_human | |
Tgene | C1961112 | Heart Decompensation | 1 | CTD_human | |
Tgene | C2350344 | Chronic Lung Injury | 1 | CTD_human | |
Tgene | C3658301 | Mycoplasma-Induced Stevens-Johnson Syndrome | 1 | CTD_human | |
Tgene | C3658302 | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 1 | CTD_human | |
Tgene | C4505456 | HIV Coinfection | 1 | CTD_human | |
Tgene | C4551595 | Biliary Cirrhosis, Primary, 1 | 1 | CTD_human | |
Tgene | C4553297 | Cystic Echinocccosis | 1 | CTD_human |